{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"cushing-syndrome-due-to-macronodular-adrenal-hyperplasia","columns":[{"gene":"","key":"population-9c25a69587d5e201f544","label":"Cushing syndrome due to bilateral macronodular adrenocortical disease","mondoId":"MONDO:0009049","onsetQualifier":null,"originColumnKey":"MONDO:0009049/ORPHA:189427","originalViews":[{"key":"MONDO:0009049/ORPHA:189427","label":"Cushing syndrome due to bilateral macronodular adrenocortical disease","scopeLabel":"ORPHA:189427","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["00e46aa6ae87c19470794c7b65011c431fbd238e5d3f3fd22974c3fc46a1efe3","09ab2fb6e09b23c5ad97a4ce9c4afd76997288cc42692d5a68e7b8dcc3e97eb3","0a2468b1d06a4e2043cc0efeb8e10dcde32148623a5a1fab3455a89073d20fb4","1f3bf0ba1c06f8770c11c893e588be6cb36b9f25ea63b68a375f321b8e266869","2220d33dfaef2a26a7eeb1c5383540f89151b2c84fbb2f38a91e7c14a731d7ec","29eee93426c7219ee4f8413e32b90e09abea465d4edb1dbd81c5d0c899bd4e30","346aab29ac1045a3944fcfddade3fa951aeb3446b33d8cfa5ccc2ec0dcc6e102","3869646a05cf905afb024c72253bf73cfe6b5dad4de899fa803cf27abc63679d","3e24eebaa4823ad1efa07080fb125ed9f44a9a091ad47807902b639b5e954ee9","40f017cda1f15cebc49f3b80e4905f4cf196cf01e25b2311dc950a3b548db45e","435f9c105668bf1929023fed0cbd1c5eb86a4453c5e0ccc59327a2d417c4bd84","4de3868afc61b8d231ff2f250cfa5f19dd780a23f276f81e724991539ba426fe","4e3c10e9a7f6de57cbf79c1321ba1057a722da655f47d571e448c46127f8792f","61c2be484958fbe83567f845760a3e46da7c2197ccd1214eb4c681a644a41f3b","63900c29ff5b3e214bc10f08d555a76bfe32345ec50c5ba3a055d09a4b474832","6c46e1d26fec67aabaca95a030c10260bdb3d9150d7bbacb06833d9dd08f1768","70825ff3ac342b8529f8b614d2a4edbd011849a5c5b6532f6bc6288fc2959158","7c7cf2b41085557a5443a615fbac865be8186129a5ffd23b36179801975c59e5","94d7c545cbf7e992b9a9cfb9e6a7e6844358090bf8e75c4e6cbd22fc121c5cf5","9852c2e91987f780e8fb5964ad2976cf045ed145217a06fdb7564c2fba3bb694","9b6c86186678ca50bfce5c25fcd7110eb64753b33119ac5ef103599d009461ab","9ccfffabac9b8a3f8e458ae37d0a1dc76a52cb5dacac248d2660c3133f95c86b","9ef43f242a5e975a6f9eae7e729a8d3898d78eeb9defe2490500d036d476c71d","aae47af49ae9bf65b8181339f18ef8912148cb376a9e7c45b1daf1b3cccea504","ab380c139870694aecded1ce9746d1fd4ce33c3a4faa13bea58feb771de4bb12","b1e0ea64397bb07841cb3883745a6b78ddbd2ecd91efdd01029b2ef8aad86f85","b2117a271b078df1458b2386ca299b3ff099cc61dad42fff6e885605725a1d35","bd2a713081223080cb48e4124febef26b8a0f6c9bc1fdab1a1f9559a9f906d23","cac49db399e198059b75d3e9995f4f84d1e72613e888ecc96f98ac67d4a930af","cf288a176a3fe0149f2fee85ddc7bd5c13a87473fa0abd9883e636c1b18d0c22","d0dda75cc2f079e4ea3eb2f271a8bfe16fe78b17572b31a531f85ecb41f462c7","d598cb5f1ff5b8b0c8a9eeac0402255c40d7362b8b00aaf17079b47561465b45","d5ec1c8c71612c3c9423f9ed61f11a23711439d8c031a97fc6e47865c98ff6df","e54835340b45f302e3f5c8ac36b14d27b14aa951382cb4b1fd92bc1d66853c45","e62a72603f270f681a42f356a11c550c703da16bc9d4424b5cdf19d58e830e6c","ee944cd02645d948b4dbe36f42ccbff336d055ccf65ffbc75aeab2f78de78ae6","f156d784a234be96fc7bb708912066328086a2ce1d4b125256bfd037f2f74ab9","f971e028eefc6cf36c1a4620231f6b52b4ef279fba09a0eec578c85fca2ac1ef","f986ff55024a579386faec5b2b4ff2a317f506361cc66f02fb303a193df7d5fb"],"recordQualifiers":{},"scopeLabel":"ORPHA:189427","sourceIds":["ORPHA:189427"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-9c25a69587d5e201f544"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0012743","HP:0031845","HP:0031077","HP:0001061","HP:0001596","HP:0000978","HP:0100543"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":39,"sourceGroups":{"orphanet":39}},"features":[{"hpoId":"HP:0012743","label":"Abdominal obesity","primary":true},{"hpoId":"HP:0031845","label":"Abnormal libido","primary":true},{"hpoId":"HP:0031077","label":"Abnormal response to corticotropin releasing hormone stimulation test","primary":true},{"hpoId":"HP:0001061","label":"Acne","primary":true},{"hpoId":"HP:0001596","label":"Alopecia","primary":true},{"hpoId":"HP:0000978","label":"Bruising susceptibility","primary":true},{"hpoId":"HP:0100543","label":"Cognitive impairment","primary":true},{"hpoId":"HP:0002920","label":"Decreased circulating ACTH concentration","primary":false},{"hpoId":"HP:0000716","label":"Depression","primary":false},{"hpoId":"HP:0025383","label":"Dorsocervical fat pad","primary":false},{"hpoId":"HP:0000712","label":"Emotional lability","primary":false},{"hpoId":"HP:0001952","label":"Glucose intolerance","primary":false},{"hpoId":"HP:0001397","label":"Hepatic steatosis","primary":false},{"hpoId":"HP:0001007","label":"Hirsutism","primary":false},{"hpoId":"HP:0003077","label":"Hyperlipidemia","primary":false},{"hpoId":"HP:0000822","label":"Hypertension","primary":false},{"hpoId":"HP:0004324","label":"Increased body weight","primary":false},{"hpoId":"HP:0000859","label":"Increased circulating aldosterone concentration","primary":false},{"hpoId":"HP:0003118","label":"Increased circulating cortisol level","primary":false},{"hpoId":"HP:0002659","label":"Increased susceptibility to fractures","primary":false},{"hpoId":"HP:0012030","label":"Increased urinary cortisol level","primary":false},{"hpoId":"HP:0000858","label":"Irregular menstruation","primary":false},{"hpoId":"HP:0000787","label":"Kidney stone","primary":false},{"hpoId":"HP:0008231","label":"Macronodular adrenal hyperplasia","primary":false},{"hpoId":"HP:0100754","label":"Mania","primary":false},{"hpoId":"HP:0002354","label":"Memory impairment","primary":false},{"hpoId":"HP:0002858","label":"Meningioma","primary":false},{"hpoId":"HP:0500011","label":"Moon facies","primary":false},{"hpoId":"HP:0100634","label":"Neuroendocrine neoplasm","primary":false},{"hpoId":"HP:0000939","label":"Osteoporosis","primary":false},{"hpoId":"HP:0003466","label":"Paradoxical increased cortisol secretion on dexamethasone suppression test","primary":false},{"hpoId":"HP:0002893","label":"Pituitary adenoma","primary":false},{"hpoId":"HP:0001050","label":"Plethora","primary":false},{"hpoId":"HP:0008200","label":"Primary hyperparathyroidism","primary":false},{"hpoId":"HP:0007126","label":"Proximal amyotrophy","primary":false},{"hpoId":"HP:0003701","label":"Proximal muscle weakness","primary":false},{"hpoId":"HP:0000725","label":"Psychotic episodes","primary":false},{"hpoId":"HP:0005584","label":"Renal cell carcinoma","primary":false},{"hpoId":"HP:0001065","label":"Striae distensae","primary":false}],"ledeHtml":"Primary macronodular adrenal hyperplasia (PMAH) is a disorder characterized by multiple lumps (nodules) in the adrenal glands, which are small hormone-producing glands located on top of each kidney. These nodules, which usually are found in both adrenal glands (bilateral) and vary in size, cause adrenal gland enlargement (hyperplasia) and result in the production of higher-than-normal levels of the hormone cortisol. Cortisol is an important hormone that suppresses inflammation and protects the body from physical stress such as infection or trauma through several mechanisms including raising levels of blood glucose, also called blood sugar. PMAH typically becomes evident in a persons forties or fifties. It is considered a form of Cushing syndrome, which is characterized by increased levels of cortisol resulting from one of many possible causes. These increased cortisol levels lead to weight gain in the face and upper body, fragile skin, bone loss, fatigue, and other health problems. However, some people with PMAH do not experience these signs and symptoms and are said to have subclinical Cushing syndrome.","mondoId":"MONDO:0009049","node":{"canonicalSlug":"cushing-syndrome-due-to-macronodular-adrenal-hyperplasia","comparisons":[{"documentSha256":"49583e08324f73599f6286e2960ea17396b9af224f2bca252f4f20a5da37149f","key":"legacy-cushing","kind":"legacy","label":"Cushing syndrome","memberIds":["MONDO:0009049","MONDO:0014416","MONDO:0018912","MONDO:0020527","MONDO:0020735","MONDO:0700299"],"mondoId":"MONDO:0018912","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/cushing.49583e08324f73599f6286e2960ea17396b9af224f2bca252f4f20a5da37149f.json"},{"documentSha256":"cb673233f80be515c641b45908367eb402e74ae5855118e864fc53d7ff963bab","key":"expanded-cushing","kind":"expanded","label":"Cushing syndrome","memberIds":["MONDO:0009049","MONDO:0009050","MONDO:0014416","MONDO:0018912","MONDO:0020527","MONDO:0020528","MONDO:0020529","MONDO:0020735","MONDO:0700299","MONDO:0800377","MONDO:0957431","MONDO:0958258","MONDO:1060126"],"mondoId":"MONDO:0018912","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-cb673233f80be515c641.cb673233f80be515c641b45908367eb402e74ae5855118e864fc53d7ff963bab.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Cushing syndrome due to macronodular adrenal hyperplasia","originalSourceId":"ORPHA:189427","paragraphs":["Primary macronodular adrenal hyperplasia (PMAH) is a disorder characterized by multiple lumps (nodules) in the adrenal glands, which are small hormone-producing glands located on top of each kidney. These nodules, which usually are found in both adrenal glands (bilateral) and vary in size, cause adrenal gland enlargement (hyperplasia) and result in the production of higher-than-normal levels of the hormone cortisol. Cortisol is an important hormone that suppresses inflammation and protects the body from physical stress such as infection or trauma through several mechanisms including raising levels of blood glucose, also called blood sugar. PMAH typically becomes evident in a persons forties or fifties. It is considered a form of Cushing syndrome, which is characterized by increased levels of cortisol resulting from one of many possible causes. These increased cortisol levels lead to weight gain in the face and upper body, fragile skin, bone loss, fatigue, and other health problems. However, some people with PMAH do not experience these signs and symptoms and are said to have subclinical Cushing syndrome."],"rawAttribution":"MONDO:0009049","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:23Z","upstream":"MONDO:0009049","url":"https://rarediseases.info.nih.gov/diseases/10824"},"ownColumnKeys":["population-9c25a69587d5e201f544"],"publication":"published","relationships":[{"kind":"parent","label":"hereditary disease","mondoId":"MONDO:0003847","slug":null},{"kind":"parent","label":"ACTH-independent Cushing syndrome","mondoId":"MONDO:0020529","slug":"acth-independent-cushing"},{"kind":"child","label":"ACTH-independent macronodular adrenal hyperplasia 2","mondoId":"MONDO:0014416","slug":"acth-independent-macronodular-adrenal-hyperplasia-2"},{"kind":"child","label":"ACTH-independent macronodular adrenal hyperplasia 1","mondoId":"MONDO:0020735","slug":"acth-independent-macronodular-adrenal-hyperplasia-1"},{"kind":"child","label":"ACTH-independent macronodular adrenal hyperplasia 3","mondoId":"MONDO:0700299","slug":"acth-independent-macronodular-adrenal-hyperplasia-3"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"multiple-identity-targets","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/primary-macronodular-adrenal-hyperplasia"}],"translation":"published"},"records":[{"frequencyKind":"range","key":"00e46aa6ae87c19470794c7b65011c431fbd238e5d3f3fd22974c3fc46a1efe3","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003701","is_excluded":false,"label":"Proximal muscle weakness","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"09ab2fb6e09b23c5ad97a4ce9c4afd76997288cc42692d5a68e7b8dcc3e97eb3","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0000859","is_excluded":false,"label":"Increased circulating aldosterone concentration","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0a2468b1d06a4e2043cc0efeb8e10dcde32148623a5a1fab3455a89073d20fb4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001952","is_excluded":false,"label":"Glucose intolerance","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1f3bf0ba1c06f8770c11c893e588be6cb36b9f25ea63b68a375f321b8e266869","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0100634","is_excluded":false,"label":"Neuroendocrine neoplasm","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2220d33dfaef2a26a7eeb1c5383540f89151b2c84fbb2f38a91e7c14a731d7ec","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002354","is_excluded":false,"label":"Memory impairment","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"29eee93426c7219ee4f8413e32b90e09abea465d4edb1dbd81c5d0c899bd4e30","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100754","is_excluded":false,"label":"Mania","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"346aab29ac1045a3944fcfddade3fa951aeb3446b33d8cfa5ccc2ec0dcc6e102","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0002858","is_excluded":false,"label":"Meningioma","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3869646a05cf905afb024c72253bf73cfe6b5dad4de899fa803cf27abc63679d","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031077","is_excluded":false,"label":"Abnormal response to corticotropin releasing hormone stimulation test","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3e24eebaa4823ad1efa07080fb125ed9f44a9a091ad47807902b639b5e954ee9","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001007","is_excluded":false,"label":"Hirsutism","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"40f017cda1f15cebc49f3b80e4905f4cf196cf01e25b2311dc950a3b548db45e","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000978","is_excluded":false,"label":"Bruising susceptibility","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"435f9c105668bf1929023fed0cbd1c5eb86a4453c5e0ccc59327a2d417c4bd84","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003118","is_excluded":false,"label":"Increased circulating cortisol level","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4de3868afc61b8d231ff2f250cfa5f19dd780a23f276f81e724991539ba426fe","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0002893","is_excluded":false,"label":"Pituitary adenoma","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4e3c10e9a7f6de57cbf79c1321ba1057a722da655f47d571e448c46127f8792f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000712","is_excluded":false,"label":"Emotional lability","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"61c2be484958fbe83567f845760a3e46da7c2197ccd1214eb4c681a644a41f3b","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002920","is_excluded":false,"label":"Decreased circulating ACTH concentration","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"63900c29ff5b3e214bc10f08d555a76bfe32345ec50c5ba3a055d09a4b474832","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0500011","is_excluded":false,"label":"Moon facies","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6c46e1d26fec67aabaca95a030c10260bdb3d9150d7bbacb06833d9dd08f1768","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0100543","is_excluded":false,"label":"Cognitive impairment","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"70825ff3ac342b8529f8b614d2a4edbd011849a5c5b6532f6bc6288fc2959158","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007126","is_excluded":false,"label":"Proximal amyotrophy","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7c7cf2b41085557a5443a615fbac865be8186129a5ffd23b36179801975c59e5","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0004324","is_excluded":false,"label":"Increased body weight","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"94d7c545cbf7e992b9a9cfb9e6a7e6844358090bf8e75c4e6cbd22fc121c5cf5","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0008231","is_excluded":false,"label":"Macronodular adrenal hyperplasia","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9852c2e91987f780e8fb5964ad2976cf045ed145217a06fdb7564c2fba3bb694","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001397","is_excluded":false,"label":"Hepatic steatosis","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9b6c86186678ca50bfce5c25fcd7110eb64753b33119ac5ef103599d009461ab","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012743","is_excluded":false,"label":"Abdominal obesity","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9ccfffabac9b8a3f8e458ae37d0a1dc76a52cb5dacac248d2660c3133f95c86b","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001065","is_excluded":false,"label":"Striae distensae","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9ef43f242a5e975a6f9eae7e729a8d3898d78eeb9defe2490500d036d476c71d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000725","is_excluded":false,"label":"Psychotic episodes","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"aae47af49ae9bf65b8181339f18ef8912148cb376a9e7c45b1daf1b3cccea504","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001061","is_excluded":false,"label":"Acne","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ab380c139870694aecded1ce9746d1fd4ce33c3a4faa13bea58feb771de4bb12","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000939","is_excluded":false,"label":"Osteoporosis","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b1e0ea64397bb07841cb3883745a6b78ddbd2ecd91efdd01029b2ef8aad86f85","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b2117a271b078df1458b2386ca299b3ff099cc61dad42fff6e885605725a1d35","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012030","is_excluded":false,"label":"Increased urinary cortisol level","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bd2a713081223080cb48e4124febef26b8a0f6c9bc1fdab1a1f9559a9f906d23","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002659","is_excluded":false,"label":"Increased susceptibility to fractures","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cac49db399e198059b75d3e9995f4f84d1e72613e888ecc96f98ac67d4a930af","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001050","is_excluded":false,"label":"Plethora","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cf288a176a3fe0149f2fee85ddc7bd5c13a87473fa0abd9883e636c1b18d0c22","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0008200","is_excluded":false,"label":"Primary hyperparathyroidism","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d0dda75cc2f079e4ea3eb2f271a8bfe16fe78b17572b31a531f85ecb41f462c7","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031845","is_excluded":false,"label":"Abnormal libido","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d598cb5f1ff5b8b0c8a9eeac0402255c40d7362b8b00aaf17079b47561465b45","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000716","is_excluded":false,"label":"Depression","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d5ec1c8c71612c3c9423f9ed61f11a23711439d8c031a97fc6e47865c98ff6df","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001596","is_excluded":false,"label":"Alopecia","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e54835340b45f302e3f5c8ac36b14d27b14aa951382cb4b1fd92bc1d66853c45","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003077","is_excluded":false,"label":"Hyperlipidemia","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e62a72603f270f681a42f356a11c550c703da16bc9d4424b5cdf19d58e830e6c","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003466","is_excluded":false,"label":"Paradoxical increased cortisol secretion on dexamethasone suppression test","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ee944cd02645d948b4dbe36f42ccbff336d055ccf65ffbc75aeab2f78de78ae6","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0025383","is_excluded":false,"label":"Dorsocervical fat pad","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f156d784a234be96fc7bb708912066328086a2ce1d4b125256bfd037f2f74ab9","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000858","is_excluded":false,"label":"Irregular menstruation","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f971e028eefc6cf36c1a4620231f6b52b4ef279fba09a0eec578c85fca2ac1ef","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0005584","is_excluded":false,"label":"Renal cell carcinoma","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f986ff55024a579386faec5b2b4ff2a317f506361cc66f02fb303a193df7d5fb","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:189427","disease_name":"Cushing syndrome due to bilateral macronodular adrenocortical disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000787","is_excluded":false,"label":"Kidney stone","onset_id":null,"reference":"ORPHA:189427","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10824\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009049\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0009049</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Primary macronodular adrenal hyperplasia (PMAH) is a disorder characterized by multiple lumps (nodules) in the adrenal glands, which are small hormone-producing glands located on top of each kidney. These nodules, which usually are found in both adrenal glands (bilateral) and vary in size, cause adrenal gland enlargement (hyperplasia) and result in the production of higher-than-normal levels of the hormone cortisol. Cortisol is an important hormone that suppresses inflammation and protects the body from physical stress such as infection or trauma through several mechanisms including raising levels of blood glucose, also called blood sugar. PMAH typically becomes evident in a persons forties or fifties. It is considered a form of Cushing syndrome, which is characterized by increased levels of cortisol resulting from one of many possible causes. These increased cortisol levels lead to weight gain in the face and upper body, fragile skin, bone loss, fatigue, and other health problems. However, some people with PMAH do not experience these signs and symptoms and are said to have subclinical Cushing syndrome.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10824\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"cushing-syndrome-due-to-macronodular-adrenal-hyperplasia","sourceDocuments":[{"name":"GARD: Cushing syndrome due to macronodular adrenal hyperplasia","reviewed":null,"source_release":"2026-10-25T03:41:23Z","url":"https://rarediseases.info.nih.gov/diseases/10824"},{"name":"MONDO: Cushing syndrome due to macronodular adrenal hyperplasia","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009049"}],"sourceNote":"","synonyms":["ACTH-independent macronodular adrenal hyperplasia","ACTH-independent macronodular adrenocortical hyperplasia","adrenocorticotropic hormone-independent macronodular adrenal hyperplasia","AIMAH","corticotropin-independent macronodular adrenal hyperplasia","massive macronodular adrenocortical disease","MMAD","primary bilateral macronodular adrenal hyperplasia","primary macronodular adrenal hyperplasia"],"takeawayHtml":"","title":"Cushing syndrome due to macronodular adrenal hyperplasia"},"schemaVersion":1}
